Zhejiang Huakang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Zhejiang Huakang Pharmaceutical has a total shareholder equity of CN¥3.2B and total debt of CN¥2.3B, which brings its debt-to-equity ratio to 73.1%. Its total assets and total liabilities are CN¥6.3B and CN¥3.1B respectively. Zhejiang Huakang Pharmaceutical's EBIT is CN¥392.2M making its interest coverage ratio 128. It has cash and short-term investments of CN¥1.7B.
Key information
73.1%
Debt to equity ratio
CN¥2.33b
Debt
Interest coverage ratio | 128x |
Cash | CN¥1.72b |
Equity | CN¥3.19b |
Total liabilities | CN¥3.08b |
Total assets | CN¥6.27b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 605077's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥855.2M).
Long Term Liabilities: 605077's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥2.2B).
Debt to Equity History and Analysis
Debt Level: 605077's net debt to equity ratio (19.3%) is considered satisfactory.
Reducing Debt: 605077's debt to equity ratio has increased from 45.4% to 73.1% over the past 5 years.
Debt Coverage: 605077's debt is not well covered by operating cash flow (17.8%).
Interest Coverage: 605077's interest payments on its debt are well covered by EBIT (128x coverage).